ISSN 1016-5169 | E-ISSN 1308-4488
ARISTOTLE study and sub-group analyses: Conspicuous points [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(2): 14-25

ARISTOTLE study and sub-group analyses: Conspicuous points

Özgür Aslan
Dokuz Eylül Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İzmir

Aristotle study is a phase III study which evaluates apixaban’s safety and efficacy as comparing to warfarin in patients with nonvalvular AF (NVAF) having at least one stroke risk factor of apixaban. 18.201 patients were evaluated in this randomized, controlled, multicentered study. This review will overview of the Aristotle study and subgroup analysis.

Keywords: Aristotle, apixaban, nonvalvular.

How to cite this article
Özgür Aslan. ARISTOTLE study and sub-group analyses: Conspicuous points. Turk Kardiyol Dern Ars. 2016; 44(2): 14-25

Corresponding Author: Özgür Aslan, Türkiye
Manuscript Language: Turkish

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2023 Archives of the Turkish Society of Cardiology